Related Experiment Video
Updated: Jul 6, 2026

Solid Lipid Nanoparticles (SLNs) for Intracellular Targeting Applications
Published on: November 17, 2015
Liposomal nanomedicines: an emerging field
David B Fenske1, Arcadio Chonn, Pieter R Cullis
1Department of Chemistry, University College of the Fraser Valley, Abbotsford, British Columbia, Canada.
Liposomal nanomedicines (LNMs) are advanced drug delivery systems that encapsulate therapeutics for targeted disease treatment. These nanoparticles protect drugs, minimize off-target effects, and accumulate at disease sites like tumors.
Area of Science:
- Nanomedicine
- Drug Delivery Systems
- Biotechnology
Background:
- Liposomal nanoparticles (LNs) are a leading class of drug delivery systems, with numerous products in clinical trials.
- Over two decades, techniques have evolved to encapsulate conventional drugs and genetic materials (DNA, siRNA) into LNs.
Purpose of the Study:
- To review recent advancements in liposomal nanomedicines (LNMs).
- To highlight applications in cancer therapy, gene delivery, and vaccine development.
Main Methods:
- Development of LNs with specific properties: ~100 nm diameter, high drug-to-lipid ratio, excellent drug retention, and long circulation (>6 hours).
- Utilizing the enhanced permeability and retention (EPR) effect for passive targeting to disease sites.
Main Results:
- LNMs demonstrate effective drug protection during circulation and targeted accumulation in diseased tissues.
- Successful encapsulation of anticancer drugs, gene-delivery agents, immunostimulatory molecules, and gene-silencing RNA.
Conclusions:
- LNMs offer significant potential for novel therapeutic strategies in oncology, vaccinology, and metabolic disease management.
- Targeted delivery via LNMs enhances therapeutic efficacy and reduces systemic toxicity.
More Related Videos
Related Concept Videos
Modified-Release Drug Delivery Systems: Site-Targeted
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Microorganisms in Medicine and Therapeutics
Bioavailability Enhancement: Drug Permeability Enhancement

